Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Abiomed Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in thousands

	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016
Accounts payable	35,070)	34,797)	35,346)	32,066)	27,621)	29,807)	34,842)	23,594)	21,734)	27,747)	32,774)	31,566)	31,736)	29,688)	32,185)	26,179)	21,884)	25,673)	23,565)	21,991)	16,667)	12,784)	20,620)	14,558)	14,066)	8,372)
Accrued expenses	69,434)	79,011)	72,629)	66,668)	56,744)	56,462)	66,046)	71,661)	57,227)	58,431)	75,107)	71,876)	57,907)	51,941)	57,420)	51,721)	46,099)	38,930)	46,147)	41,565)	35,256)	35,695)	37,703)	34,539)	28,013)	26,257)
Deferred revenue	25,962)	23,624)	26,362)	24,867)	24,078)	24,094)	24,322)	21,291)	21,314)	19,903)	19,147)	19,156)	19,322)	16,193)	16,393)	15,080)	13,996)	12,075)	14,970)	11,797)	10,584)	9,697)	10,495)	9,004)	9,103)	8,590)
Other current liabilities	3,594)	3,330)	4,120)	3,195)	5,579)	2,760)	3,759)	3,854)	4,938)	4,298)	4,857)	3,661)	3,264)	2,379)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Current portion of capital lease obligation	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	851)	829)	799)	770)	740)	—)
Current liabilities	134,060)	140,762)	138,457)	126,796)	114,022)	113,123)	128,969)	120,400)	105,213)	110,379)	131,885)	126,259)	112,229)	100,201)	105,998)	92,980)	81,979)	76,678)	84,682)	75,353)	63,358)	59,005)	69,617)	58,871)	51,922)	43,219)
Other long-term liabilities	7,013)	7,792)	9,319)	10,805)	8,303)	11,314)	10,162)	16,974)	11,684)	9,380)	9,305)	12,227)	9,626)	11,502)	1,061)	1,185)	889)	815)	776)	466)	598)	588)	3,251)	17)	4)	213)
Contingent consideration	14,995)	18,151)	21,510)	21,539)	22,314)	25,577)	24,706)	25,316)	24,417)	23,701)	9,000)	10,440)	10,236)	9,931)	9,575)	10,583)	10,493)	10,331)	10,490)	10,423)	9,835)	9,418)	9,153)	8,175)	7,749)	7,739)
Deferred tax liabilities	689)	735)	781)	799)	832)	858)	847)	4,303)	4,251)	4,204)	806)	822)	800)	833)	822)	838)	850)	856)	903)	878)	866)	837)	783)	771)	821)	814)
Capital lease obligation, net of current portion	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	15,110)	15,325)	15,539)	15,750)	15,961)	—)
Long-term liabilities	22,697)	26,678)	31,610)	33,143)	31,449)	37,749)	35,715)	46,593)	40,352)	37,285)	19,111)	23,489)	20,662)	22,266)	11,458)	12,606)	12,232)	12,002)	12,169)	11,767)	26,409)	26,168)	28,726)	24,713)	24,535)	8,766)
Total liabilities	156,757)	167,440)	170,067)	159,939)	145,471)	150,872)	164,684)	166,993)	145,565)	147,664)	150,996)	149,748)	132,891)	122,467)	117,456)	105,586)	94,211)	88,680)	96,851)	87,120)	89,767)	85,173)	98,343)	83,584)	76,457)	51,985)
Class B Preferred Stock, $.01 par value; none issued and outstanding	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Common stock, $.01 par value	452)	456)	455)	455)	455)	454)	453)	452)	452)	450)	451)	451)	452)	454)	451)	451)	450)	449)	444)	443)	442)	441)	437)	435)	433)	430)
Additional paid in capital	904,755)	884,965)	870,074)	853,210)	840,387)	815,416)	800,690)	781,903)	767,527)	749,440)	739,133)	733,054)	722,020)	704,884)	690,507)	676,171)	660,132)	637,974)	619,905)	605,697)	592,081)	580,017)	565,962)	546,796)	536,859)	520,842)
Retained earnings (accumulated deficit)	1,125,199)	1,019,066)	964,512)	904,187)	858,435)	801,482)	828,007)	771,151)	709,283)	647,070)	602,482)	570,683)	501,467)	488,396)	399,473)	325,513)	280,650)	230,523)	140,457)	103,610)	90,164)	65,661)	(46,959)	(61,858)	(77,290)	(86,165)
Treasury stock at cost	(443,974)	(330,020)	(304,555)	(304,425)	(300,158)	(297,619)	(288,030)	(287,896)	(287,654)	(286,577)	(265,411)	(240,330)	(214,926)	(179,386)	(138,852)	(138,289)	(136,743)	(134,674)	(67,078)	(66,622)	(65,999)	(64,567)	(46,763)	(46,556)	(46,266)	(41,691)
Accumulated other comprehensive loss	(46,645)	(38,271)	(27,160)	(20,489)	(14,556)	(12,211)	(11,445)	(4,169)	(7,199)	(8,535)	(11,189)	(16,995)	(17,556)	(11,755)	(14,689)	(12,316)	(11,535)	(10,913)	(4,204)	(10,646)	(11,802)	(14,508)	(20,606)	(21,437)	(15,295)	(16,089)
Stockholders’ equity	1,539,787)	1,536,196)	1,503,326)	1,432,938)	1,384,563)	1,307,522)	1,329,675)	1,261,441)	1,182,409)	1,101,848)	1,065,466)	1,046,863)	991,457)	1,002,593)	936,890)	851,530)	792,954)	723,359)	689,524)	632,482)	604,886)	567,044)	452,071)	417,380)	398,441)	377,327)
Total liabilities and stockholders’ equity	1,696,544)	1,703,636)	1,673,393)	1,592,877)	1,530,034)	1,458,394)	1,494,359)	1,428,434)	1,327,974)	1,249,512)	1,216,462)	1,196,611)	1,124,348)	1,125,060)	1,054,346)	957,116)	887,165)	812,039)	786,375)	719,602)	694,653)	652,217)	550,414)	500,964)	474,898)	429,312)

Accounts Payable: Accounts payable exhibited a generally increasing trend from mid-2016 through mid-2022, rising from 8,372 thousand USD to approximately 35,070 thousand USD. There were notable fluctuations, with periodic decreases followed by rebounds, but the overall pattern indicates growth in short-term obligations to suppliers.
Accrued Expenses: Accrued expenses showed a consistent upward trajectory over the period, increasing from 26,257 thousand USD in mid-2016 to a peak above 79,000 thousand USD in late 2022. This indicates growing obligations for incurred but not yet paid expenses, with some seasonal variability visible within individual years.
Deferred Revenue: Deferred revenue steadily increased from around 8,590 thousand USD in mid-2016 to a value near 26,000 thousand USD by the end of the dataset. The increases, while somewhat irregular quarter-over-quarter, reflect growing advance payments or unearned income during the period.
Other Current Liabilities: Data for other current liabilities was sparse but appeared from early 2019 onwards, ranging between approximately 2,379 thousand USD and 5,579 thousand USD. These liabilities displayed some variability without a clear increasing or decreasing trend.
Current Portion of Capital Lease Obligation: This liability item is reported with limited data, primarily in 2016 and 2017 quarters, showing a small but steady increase within that timeframe, going from 740 thousand USD to 851 thousand USD, then ceasing to be recorded.
Current Liabilities (Total): The aggregate current liabilities, encompassing the aforementioned components, showed a strong upward trend from 43,219 thousand USD in June 2016 to a peak over 140,000 thousand USD in late 2022. The changes reflect overall growth in short-term financial obligations.
Other Long-term Liabilities: Other long-term liabilities were initially minimal but displayed substantial increases in the focal years, particularly around 2019, reaching values up to approximately 12,227 thousand USD before gradually declining. These changes indicate shifting long-term obligations over time.
Contingent Consideration: The contingent consideration steadily increased from roughly 7,739 thousand USD in mid-2016 to a plateau around the mid-to-high 20,000 thousands by 2021. A notable drop occurred in the latter part of 2022, suggesting settlement or remeasurement of contingent liabilities.
Deferred Tax Liabilities: Deferred tax liabilities remained relatively stable but low, fluctuating slightly between approximately 689 thousand USD and 903 thousand USD, except for a temporary spike around 2020 where it exceeded 4,000 thousand USD, indicating some exceptional tax timing differences during that period.
Capital Lease Obligation, net of Current Portion: Data for this item was limited to 2016-2017, showing a gradual decline from 15,961 thousand USD to 15,110 thousand USD, indicating the amortization or repayment of these lease obligations.
Long-term Liabilities (Total): Long-term liabilities exhibited significant volatility with a notable increase from 8,766 thousand USD in mid-2016, peaking intensely above 46,000 thousand USD by late 2020, before moderating to around 22,697 thousand USD by late 2022. This suggests periods of increased borrowing or accrual of long-term obligations followed by repayment or restructuring.
Total Liabilities: Total liabilities combined both current and long-term obligations and displayed a rising trend from approximately 51,985 thousand USD to over 167,000 thousand USD during the analyzed period. The liabilities peaked around 2022, reflecting an expansion in the company's total financial obligations.
Common Stock: Common stock par value remained relatively constant, increasing slightly from 430 thousand USD to approximately 456 thousand USD, indicating minor changes in share capital through the period.
Additional Paid-in Capital: Additional paid-in capital steadily increased from about 520,842 thousand USD in June 2016 to approximately 904,755 thousand USD by the latest period, reflecting ongoing equity financing or capitalization events.
Retained Earnings: Retained earnings saw substantial improvement, transitioning from a negative balance of -86,165 thousand USD to a positive balance exceeding 1,125,000 thousand USD. This reflects sustained profitability and earnings retention over time.
Treasury Stock at Cost: Treasury stock value grew significantly in absolute terms (negative balance deepened), from -41,691 thousand USD to nearly -444,000 thousand USD, indicating continuous repurchase or holdings of company stock during the period.
Accumulated Other Comprehensive Loss: This category displayed increasing cumulative losses over time, starting at -16,089 thousand USD and increasing to -46,645 thousand USD. The pattern suggests growing unrealized losses or other comprehensive expense components.
Stockholders’ Equity: Stockholders’ equity consistently expanded from approximately 377,327 thousand USD to over 1,539,787 thousand USD, signaling robust growth in net assets alongside increases in retained earnings and paid-in capital, despite treasury stock and comprehensive losses.
Total Liabilities and Stockholders’ Equity: The sum of liabilities and stockholders’ equity showed a strong growth trajectory from about 429,312 thousand USD to approximately 1,696,544 thousand USD. This overall increase corresponds with expansion in the company’s balance sheet size over the analyzed period.

AI Ask an analyst for more

Download chart

Abiomed Inc. (NASDAQ:ABMD)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data